Cart
sales@molnova.com
iNOS inhibitor 12
CAS No. 268730-08-1
iNOS inhibitor 12( —— )
Catalog No. M13822 CAS No. 268730-08-1
iNOS inhibitor 12 is a potent, highly selective iNOS inhibitor with IC50 of 79 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameiNOS inhibitor 12
-
NoteResearch use only, not for human use.
-
Brief DescriptioniNOS inhibitor 12 is a potent, highly selective iNOS inhibitor with IC50 of 79 nM.
-
DescriptioniNOS inhibitor 12 is a potent, highly selective iNOS inhibitor with IC50 of 79 nM, dispalys almost 100-fold selectivity over eNOS and nNOS.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorNOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number268730-08-1
-
Formula Weight336.395
-
Molecular FormulaC19H20N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name4-(4-((4-methoxypyridin-2-yl)amino)piperidine-1-carbonyl)benzonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Garcin ED, et al. Nat Chem Biol. 2008 Nov;4(11):700-7.
2. Connolly S, et al. J Med Chem. 2004 Jun 3; 47(12):3320-3.
molnova catalog
related products
-
iNOS-IN-14
iNOS-IN-14 (3-bromo-1H-indazole-7-carbonitrile) is a potent nitric oxide synthase (NOS) inhibitor that inhibits the NADPH oxidase activity of nNOS.
-
NOC-5
NOC-5 is an NO donor that induces airway relaxation and concentration-dependently triggers 10 μM DAF-2 fluorescence.
-
3-O-Acetyl-16 alpha-...
3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid shows anti-inflammatory activity it can inhibit NO production and iNOS expression in LPS-stimulated Raw264.7 cells.
